Notes Payable (Details Narrative)
|
|
|
|
|
|
|
|
12 Months Ended |
|
|
Apr. 09, 2018
USD ($)
shares
|
Apr. 03, 2018
USD ($)
shares
|
Mar. 16, 2018
USD ($)
shares
|
Feb. 16, 2018
$ / shares
shares
|
Feb. 16, 2018
USD ($)
$ / shares
shares
|
Feb. 01, 2018 |
Aug. 23, 2017
USD ($)
|
Oct. 07, 2016
USD ($)
$ / shares
shares
|
Dec. 31, 2018
USD ($)
shares
|
Dec. 31, 2017
USD ($)
Integer
$ / shares
shares
|
Feb. 14, 2018
USD ($)
|
Jan. 22, 2018
USD ($)
|
Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Convertible note principal amount |
|
|
|
|
|
|
|
|
|
|
$ 55,000
|
|
Fair value of warrants |
$ 247,360
|
|
|
|
|
|
|
|
|
|
|
|
Amortization of debt discount |
|
|
|
|
|
|
|
|
$ 528,929
|
$ 2,285,173
|
|
|
Fair value of issuance of share |
|
$ 70,000
|
|
|
|
|
|
|
|
|
|
|
Debt instrument conversion value |
|
|
|
|
|
|
|
|
4,353,988
|
|
|
|
Gain on settlement |
|
|
|
|
|
|
|
|
2,136,860
|
|
|
|
Issuance of share common stock | shares |
|
25,669
|
|
|
|
|
|
|
|
11,503
|
|
|
Warrant to purchase of common stock | shares |
1,030,115
|
|
|
|
|
|
|
|
|
|
|
|
Debt instrument interest rate |
|
|
|
|
|
|
|
|
|
|
8.00%
|
|
Repayment of debt |
|
|
|
|
$ 688,238
|
|
|
|
55,000
|
|
|
|
Repayment of debt principal amount |
|
|
|
|
$ 545,000
|
|
|
|
|
|
|
|
Aggregate of principal and interest converted into common stock |
|
|
|
|
|
|
|
|
|
|
|
|
Interest expense, net |
|
|
|
|
|
|
|
|
$ 106,060
|
$ 946,131
|
|
|
Series D Convertible Preferred Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Number of Series D Convertible Preferred Stock issued | shares |
|
|
|
12,005
|
12,005
|
|
|
|
5,141
|
0
|
|
|
Fair value of issuance of share |
|
|
|
|
$ 12,005,000
|
|
|
|
|
|
|
|
Debt instrument conversion value |
|
|
|
|
$ 17,805,175
|
|
|
|
|
|
|
|
Gain on settlement |
|
|
|
|
|
|
|
|
$ 5,800,175
|
|
|
|
JMJ Promissory Note [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Warrant exercise price, shares | shares |
|
|
|
|
|
|
|
|
|
100,001
|
|
|
Aggregate borrowing value |
|
|
|
|
|
|
|
|
|
$ 3,500,000
|
|
|
Number of warrants | Integer |
|
|
|
|
|
|
|
|
|
10
|
|
|
Aggregate warrant exercise price |
|
|
|
|
|
|
|
|
|
$ 3,500,000
|
|
|
Fair value of warrants |
|
|
|
|
|
|
|
|
|
147,569
|
|
|
Amortization of debt discount |
|
|
|
|
|
|
|
|
|
2,610,568
|
|
|
Original issue discount |
|
|
|
|
|
|
|
|
|
499,435
|
|
|
Amortization expense |
|
|
|
|
|
|
|
|
|
2,133,865
|
|
|
Accrued default penalty |
|
|
|
|
|
|
|
|
|
12,000,000
|
|
|
Other Notes [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Repayment of debt |
|
|
|
|
|
|
|
|
50,000
|
|
|
|
Repayment of debt principal amount |
|
|
|
|
|
|
|
|
160,000
|
|
|
|
Aggregate principal repayments |
|
|
|
|
|
|
|
|
|
4,815
|
|
|
Other Notes [Member] | Lenders [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Fair value of warrants |
|
|
|
|
|
|
|
|
|
$ 52,260
|
|
|
Debt instrument interest rate |
|
|
|
|
|
|
|
|
|
12.00%
|
|
|
Other notes |
|
|
|
|
|
|
|
|
|
$ 260,000
|
|
|
Maximum equity investors or through debt financings notes mature value |
|
|
|
|
|
|
|
|
|
$ 5,000,000
|
|
|
Warrant shares issued in connection with note issuances | shares |
|
|
|
|
|
|
|
|
|
15,600
|
|
|
Warrant exercise price per share | $ / shares |
|
|
|
|
|
|
|
|
|
$ 35.00
|
|
|
Warrant description |
|
|
|
|
|
|
|
|
|
The Company issued five-year warrants to purchase an aggregate of 15,600 shares of common stock at an exercise price equal to the lower of $35.00 per share or a price equal to a 20% discount to the price per share sold in any equity financing transaction within the next twelve months whereby the Company cumulatively receives at least $1,000,000.
|
|
|
Other Notes Payable [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Repayment of debt principal amount |
|
|
|
|
|
|
|
|
$ 50,000
|
|
|
|
Public Offering [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of share common stock | shares |
|
|
|
4,353,000
|
|
|
|
|
|
|
|
|
Warrant to purchase of common stock | shares |
|
|
|
8,706,000
|
8,706,000
|
|
|
|
|
|
|
|
Warrant exercise price per share | $ / shares |
|
|
|
$ 4.25
|
$ 4.25
|
|
|
|
|
|
|
|
JMJ [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Fair value of warrants |
$ 35,313
|
|
|
|
|
|
|
|
|
|
|
|
Fair value of issuance of share |
|
|
$ 205,881
|
|
|
|
|
|
|
|
|
|
Due to related party |
|
|
|
|
|
|
|
|
|
|
|
$ 250,000
|
Issuance of share common stock | shares |
|
|
73,529
|
|
|
|
|
|
|
|
|
|
Warrant to purchase of common stock | shares |
147,058
|
|
|
|
|
|
|
|
|
|
|
|
JMJ [Member] | Public Offering [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Conversion of notes into common stock, description |
|
|
|
|
|
On February 1, 2018, the Company and JMJ entered into a letter agreement whereby the parties agreed that, concurrent with the closing of the public offering, the Company will convert the JMJ Advance into units, with each unit consisting of one share of restricted common stock and a warrant to purchase one share of restricted common stock at an exercise price equal to the exercise price of the warrants sold as part of the public offering, at a price equal to 80% of the per unit price in the public offering.
|
|
|
|
|
|
|
Farkas Group Inc. [Member] | Convertible Notes Payable [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Convertible note principal amount |
|
|
|
|
|
|
|
|
|
$ 50,000
|
|
|
Debt instrument interest rate |
|
|
|
|
|
|
|
|
|
15.00%
|
|
|
Debt instrument convertible price per shares | $ / shares |
|
|
|
|
|
|
|
|
|
$ 35.00
|
|
|
BLNK Holdings, LLC [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Aggregate principal repayments |
|
|
|
|
|
|
|
|
|
$ 5,078
|
|
|
BLNK Holdings, LLC [Member] | Convertible Notes Payable [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Convertible note principal amount |
|
|
|
|
|
|
|
|
|
$ 207,645
|
|
|
Debt instrument interest rate |
|
|
|
|
|
|
|
|
|
10.00%
|
|
|
Securities and Purchase Agreement [Member] | JMJ Promissory Note [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Fair value of obligation |
|
|
|
|
|
|
|
|
|
$ 1,680,000
|
|
|
Securities and Purchase Agreement [Member] | JMJ [Member] | Public Offering [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Conversion of notes into common stock, description |
|
|
|
|
|
|
|
(a) 80% of the per share price of the common stock in the Company's contemplated public offering, (b) $35.00 per share, (c) 80% of the unit price in the public offering (if applicable), (d) the exercise price of any warrants issued in the public offering, or (e) the lowest conversion price, exercise price, or exchange price, of any security issued by the Company that is outstanding on October 13, 2016.
|
|
|
|
|
Common stock price per shares | $ / shares |
|
|
|
|
|
|
|
$ 35.00
|
|
|
|
|
Securities and Purchase Agreement [Member] | JMJ [Member] | February 15, 2018 [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Convertible note principal amount |
|
|
|
|
|
|
|
$ 3,725,000
|
|
|
|
|
Warrant term |
|
|
|
|
|
|
|
5 years
|
|
|
|
|
Warrant exercise price, shares | shares |
|
|
|
|
|
|
|
100,001
|
|
|
|
|
Promissory Note [Member] | JMJ Promissory Note [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Aggregate borrowing value |
|
|
|
|
|
|
|
|
|
$ 3,725,000
|
|
|
BLNK Conversion Agreement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Debt instrument, description |
|
|
|
|
|
|
|
|
|
On January 4, 2018, the parties agreed to extend the expiration date of the BLNK Conversion Agreement from December 29, 2017 to February 14, 2018.
|
|
|
BLNK Conversion Agreement [Member] | BLNK Holdings, LLC [Member] | Public Offering [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Conversion of notes into common stock, description |
|
|
|
|
|
|
(i) the debt amount multiplied by a factor of 1.15 and (ii) then divided by 80% of the per share price of common stock sold in the public offering.
|
|
|
|
|
|
Aggregate of principal and interest converted into common stock |
|
|
|
|
|
|
$ 209,442
|
|
|
|
|
|